ZIVO Bioscience (NASDAQ:ZIVOW) Shares Down 12.5%
ZIVO Bioscience (NASDAQ:ZIVOW) Shares Down 12.5%
(Get Rating) Shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) fell 12.5% during trading on Friday . The stock traded as low as $0.60 and last traded at $0.63. 2,500 shares changed hands during mid-day trading, a decline of 42% from the average session volume of 4,339 shares. The stock had previously closed at $0.72.
ZIVO Bioscience, Inc.（纳斯达克股票代码：ZIVOW — 获取评级）的股价在周五的交易中下跌了12.5％。该股交易价格低至0.60美元，最后一次交易价格为0.63美元。2,500股在午盘交易中易手，较4,339股的平均交易量下降了42％。该股此前收于0.72美元。
ZIVO Bioscience Price Performance
ZIVO 生物科学的价格表现
The company has a 50 day moving average of $0.75 and a 200 day moving average of $0.74.
该公司的50天移动平均线为0.75美元，200天移动平均线为0.74美元。
Institutional Investors Weigh In On ZIVO Bioscience
机构投资者关注ZIVO Bioscience
An institutional investor recently raised its position in ZIVO Bioscience stock. Warberg Asset Management LLC grew its holdings in ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 84,654 shares of the company's stock after acquiring an additional 69,034 shares during the quarter. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 at the end of the most recent reporting period.
一位机构投资者最近提高了其在ZIVO Bioscience股票中的头寸。根据美国证券交易委员会（SEC）的最新披露，Warberg Asset Management LLC在第三季度将其在ZIVO Bioscience, Inc.（纳斯达克股票代码：ZIVOW — 获取评级）的持股量增加了442.0％。该机构投资者在本季度又收购了69,034股股票后，拥有该公司84,654股股票。截至最近报告期末，Warberg Asset Management LLC在ZIVO Bioscience的持股价值51,000美元。
ZIVO Bioscience Company Profile
ZIVO 生物科学公司简介
(Get Rating)
（获取评分）
ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.
ZIVO Bioscience, Inc 是一家总部位于密歇根州的生物技术/农业科技公司，致力于利用其专有藻类培养物的生物活性化合物的免疫健康和营养益处。开发渠道包括用作膳食补充剂和功能性食品原料的天然产品，以及旨在为人类和动物提供药物和药物功效的创新、生物衍生和合成的候选产品，特别侧重于调节免疫和炎症反应。
Featured Stories
精选故事
- Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
- How to Invest in the Top Grocery Stocks for This Year
- Array Technologies Brings Solar Flare To 2023 Earnings Forecast
- Best Bank Stocks to Invest in Ahead of Rising Interest Rates
- How to Invest in Farmland: 7 Simple Ways
- ExxonMobil Gushes To New Highs
- 免费获取 StockNews.com 关于 ZIVO Bioscience (ZIVOW) 的研究报告的副本
- 如何投资今年最热门的杂货股
- Array Technologies将太阳耀斑带入
- 在利率上升之前投资的最佳银行股
- 如何投资农田：7 种简单方法
- 埃克森美孚飙升至新高
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
接收 ZIVO 生物科学日报的新闻和收视率 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收ZIVO Bioscience及相关公司最新新闻和分析师评级的简明每日摘要。
